June 9, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked and Available in Europe

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers Leiden, Netherlands and Madison, WI USA. (June 9, 2020) Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System(OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in Europe.... Read more

May 27, 2020 Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal M&A, Partnerships Other Lab Products/Services

Thermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services

Thermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services WALTHAM, Mass. and KING OF PRUSSIA, Penn., May 27, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and global biotechnology company, CSL Limited (ASX:CSL;USOTC:CSLLY) today announced they have entered into a strategic partnership to help meet... Read more

May 14, 2020 Licensing, IP, and Legal Liq. Handling & Robotics

Brooks to Participate in the UBS Virtual Global Healthcare Conference

CHELMSFORD, Mass., May 14, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that company management will participate in the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020 at 1:20 p.m. ET.  The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks (Nasdaq: BRKS) is... Read more

May 12, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit

Qualitative Test for the Detection of Nucleic Acid From SARS-CoV-2 IRVINE, Calif., (May 12, 2020) — Zymo Research announced today that the US Food and Drug Administration (FDA) has approved its Quick SARS-CoV-2 rRT-PCR Kit (R3011) for Emergency Use Authorization (EUA) for the detection of SARS-CoV-2, the virus that causes COVID-19. The kit is a qualitative test for the... Read more

April 28, 2020 Licensing, IP, and Legal Product Launch

New 6-year data for Roche’s OCREVUS (ocrelizumab) show earlier treatment initiation nearly halves risk of needing walking aid in relapsing multiple sclerosis

Post-hoc analysis from 6 years of Phase III open-label extension studies showed OCREVUS treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from interferon beta-1a two years later Separate analysis showed OCREVUS slowed thalamic volume loss in patients with RMS and... Read more

April 28, 2020 Licensing, IP, and Legal

Roche’s risdiplam shows significant improvement in survival and motor milestones in infants with Type 1 spinal muscular atrophy (SMA)

FIREFISH Part 2 study met its primary endpoint by demonstrating a significant increase in motor milestones in infants aged 1-7 months after 12 months of treatment Large, pivotal global study confirms clinically meaningful efficacy seen in the dose-finding Part 1 of the trial Safety was consistent with the safety profile observed to date and no... Read more

April 27, 2020 Lab Top-10 Licensing, IP, and Legal

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ New FDA-cleared Microbroth Dilution Susceptibility Plates offer immediate testing options to microbiology laboratories providing the most up-to-date therapy for critically ill patients BASINGSTOKE, England, April 27, 2020 /PRNewswire/ — The antimicrobials Cefiderocol and imipenem/relebactam are now available on... Read more

April 17, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Promega successfully completes first fully remote quality surveillance assessment amid COVID-19 restrictions

Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. (April 17, 2020) Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day... Read more